NF-κB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II
- 1 January 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 294 (1) , C372-C379
- https://doi.org/10.1152/ajpcell.00186.2007
Abstract
Angiotensin II (ANG II) increases oxidative stress and is associated with increased risk of sudden cardiac death. The cardiac Na+ channel promoter contains elements that confer redox sensitivity. We tested the hypothesis that ANG II-mediated oxidative stress may modulate Na+ channel current through altering channel transcription. In H9c2 myocytes treated for 48 h with ANG II (100 nmol/l) or H2O2 (10 μmol/l) showed delayed macroscopic inactivation, increased late current, and 59.6% and 53.8% reductions in Na+ current, respectively (P ≤ 0.01). By quantitative real-time RT-PCR, the cardiac Na+ channel (scn5a) mRNA abundance declined by 47.3% (P < 0.01) in H9c2 myocytes treated for 48 h with 100 nmol/l ANG II. A similar change occurred with 20 μmol/l H2O2 (46.9%, P < 0.01) after 48 h. Comparable effects were seen in acutely isolated ventricular myocytes. The effects of ANG II could be inhibited by prior treatment of H9c2 cells with scavengers of reactive oxygen species or an inhibitor of the NADPH oxidase. Mutation of the scn5a promoter NF-κB binding site prevented decreased activity in response to ANG II and H2O2. Gel shift and chromosomal immunoprecipitation assays confirmed that nuclear factor (NF)-κB bound to the scn5a promoter in response to ANG II and H2O2. Overexpression of the p50 subunit of NF-κB in H9c2 cells reduced scn5a mRNA (77.3%, P < 0.01). In conclusion, ANG II can decrease scn5a transcription and current. This effect appears to be through production of H2O2 resulting in NF-κB binding to the Na+ channel promoter.Keywords
This publication has 52 references indexed in Scilit:
- Human Heart Failure Is Associated With Abnormal C-Terminal Splicing Variants in the Cardiac Sodium ChannelCirculation Research, 2007
- A possible mechanism of halocarbon-induced cardiac sensitization arrhythmiasJournal of Molecular and Cellular Cardiology, 2006
- The Role of the Persistent Na+ Current During Cardiac Ischemia and HypoxiaJournal of Cardiovascular Electrophysiology, 2006
- Tandem Promoters and Developmentally Regulated 5′- and 3′-mRNA Untranslated Regions of the Mouse Scn5a Cardiac Sodium ChannelPublished by Elsevier ,2005
- Angiotensin II Regulation of Collagen Type I Expression in Cardiac FibroblastsHypertension, 2004
- Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsAmerican Heart Journal, 2004
- Responses to the proinflammatory cytokines interleukin‐1 and tumor necrosis factor α in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor κB–mediated induction of the Ets transcription factor ESE‐1Arthritis & Rheumatism, 2003
- Aldosterone and Aldosterone Antagonism in Cardiovascular DiseaseHeart Disease, 2003
- Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling PathwayJournal of Molecular and Cellular Cardiology, 2000
- The enhancement of phosphatidylcholine biosynthesis by angiotensin II in H9c2 cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995